Loading provider…
Loading provider…
Hematology & Oncology Physician in Covington, LA
NPI: 1750346938Primary Employer
East Jefferson Physicians Group LLC
lcmchealth.org
HQ Phone
Mobile
Get MD Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardLA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 134 | 220 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 94 | 341 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 21 | 21 |
| 4 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 14 | 19 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 11 | 11 |
Authors: Ray Page, Robert Motzer, Thomas Flaig, Noah Berkowitz, J Beck
Journal: Ann Oncol
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.
Authors: Thomas Lowe, Heather Wakelee, William Lawler, Tarek Mekhail, Fadi Braiteh
Publication Date: 2016-04-05
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.
Authors: Ray Page, Robert Motzer
Publication Date: 2014-07-23
Lead Sponsor: Stemline Therapeutics, Inc.
Intervention / Treatment: DRUG: Standard of Care, DRUG: Elacestrant
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
Lead Sponsor: PharmaMar
Intervention / Treatment: DRUG: Topotecan, DRUG: Cyclophosphamide (CTX), DRUG: Lurbinectedin (PM01183), DRUG: Doxorubicin (DOX), DRUG: Vincristine (VCR)